The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Effect of Transendocardial Delivery of Autologous Bone Marrow Mononuclear Cells on Functional Capacity, Left Ventricular Function, and Perfusion in Chronic Heart Failure: The FOCUS-CCTRN Trial
Open accessAbstract
CONTEXT: Previous studies using autologous bone marrow mononuclear cells (BMCs) in patients with ischemic cardiomyopathy have demonstrated safety and suggested efficacy. OBJECTIVE: To determine if administration of BMCs through transendocardial injections improves myocardial perfusion, reduces left ventricular end-systolic volume (LVESV), or enhances maximal oxygen consumption in patients with coronary artery disease or LV dysfunction, and limiting heart failure or angina. DESIGN, SETTING, AND PATIENTS: A phase 2 randomized double-blind, placebo-controlled trial of symptomatic patients (New York Heart Association classification II-III or Canadian Cardiovascular Society classification II-IV) with a left ventricular ejection fraction of 45% or less, a perfusion defect by single-photon emission tomography (SPECT), and coronary artery disease not amenable to revascularization who were receiving maximal medical therapy at 5 National Heart, Lung, and Blood Institute-sponsored Cardiovascular Cell Therapy Research Network (CCTRN) sites between April 29, 2009, and April 18, 2011. INTERVENTION: Bone marrow aspiration (isolation of BMCs using a standardized automated system performed locally) and transendocardial injection of 100 million BMCs or placebo (ratio of 2 for BMC group to 1 for placebo group). MAIN OUTCOME MEASURES: Co-primary end points assessed at 6 months: changes in LVESV assessed by echocardiography, maximal oxygen consumption, and reversibility on SPECT. Phenotypic and functional analyses of the cell product were performed by the CCTRN biorepository core laboratory. RESULTS: Of 153 patients who provided consent, a total of 92 (82 men; average age: 63 years) were randomized (n = 61 in BMC group and n = 31 in placebo group). Changes in LVESV index (-0.9 mL/m(2) [95% CI, -6.1 to 4.3]; P = .73), maximal oxygen consumption (1.0 [95% CI, -0.42 to 2.34]; P = .17), and reversible defect (-1.2 [95% CI, -12.50 to 10.12]; P = .84) were not statistically significant. There were no differences found in any of the secondary outcomes, including percent myocardial defect, total defect size, fixed defect size, regional wall motion, and clinical improvement. CONCLUSION: Among patients with chronic ischemic heart failure, transendocardial injection of autologous BMCs compared with placebo did not improve LVESV, maximal oxygen consumption, or reversibility on SPECT. TRIAL REGISTRATION: clinicaltrials.gov Identifier: NCT00824005.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lang, R. M., Bierig, M., Devereux, R. B., Flachskampf, F. A., Foster, E., Pellikka, P. A., Picard, M. H., Roman, M. J., Seward, J., Shanewise, J. S., et al. (2005) · Journal of the American Society of Echocardiography · doi:10.1016/j.echo.2005.10.005 · Cited by 11,318
Isolation of Putative Progenitor Endothelial Cells for Angiogenesis
Asahara, T., Murohara, T., Sullivan, A., Silver, M., van der Zee, R., Li, T., Witzenbichler, B., Schatteman, G., & Isner, J. M. (1997) · Science · doi:10.1126/science.275.5302.964 · Cited by 8,725
Recommendations for chamber quantification☆
LANG, R., BIERIG, M., DEVEREUX, R., FLACHSKAMPF, F., FOSTER, E., PELLIKKA, P., PICARD, M., ROMAN, M., SEWARD, J., & SHANEWISE, J. (2006) · European Journal of Echocardiography · doi:10.1016/j.euje.2005.12.014 · Cited by 3,571
Moher, D., Schulz, K. F., & Altman, D. G. (2001) · BMC Medical Research Methodology · doi:10.1186/1471-2288-1-2 · Cited by 2,755
Moher, D. (2001) · JAMA · doi:10.1001/jama.285.15.1987 · Cited by 2,545
O'Connor (2009) · doi:10.1001/jama.2009.454 · Cited by 2,173
Perin, E. C., Dohmann, H. F. R., Borojevic, R., Silva, S. A., Sousa, A. L. S., Mesquita, C. T., Rossi, M. I. D., Carvalho, A. C., Dutra, H. S., Dohmann, H. J. F., et al. (2003) · Circulation · doi:10.1161/01.cir.0000070596.30552.8b · Cited by 1,290
Self-citationTranscoronary Transplantation of Progenitor Cells after Myocardial Infarction
Assmus, B., Honold, J., Schächinger, V., Britten, M. B., Fischer-Rasokat, U., Lehmann, R., Teupe, C., Pistorius, K., Martin, H., Abolmaali, N. D., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa051779 · Cited by 1,040
Adult Bone Marrow–Derived Cells for Cardiac Repair: A Systematic Review and Meta-analysis
Abdel-Latif, A. (2007) · Archives of Internal Medicine · doi:10.1001/archinte.167.10.989 · Cited by 880
Cha, M., Eastwaad, S., Hartan, R., Maher, D., Olkin, I., Pitkin, R., Rennie, D., Schulz, K. F., Simel, D. L., & Straup, D. F. (1996) · Cited by 737
Heeschen, C., Lehmann, R., Honold, J., Assmus, B., Aicher, A., Walter, D. H., Martin, H., Zeiher, A. M., & Dimmeler, S. (2004) · Circulation · doi:10.1161/01.cir.0000124476.32871.e3 · Cited by 618
Losordo, D. W., Schatz, R. A., White, C. J., Udelson, J. E., Veereshwarayya, V., Durgin, M., Poh, K. K., Weinstein, R., Kearney, M., Chaudhry, M., et al. (2007) · Circulation · doi:10.1161/circulationaha.106.687376 · Cited by 557
Self-citationAutologous bone marrow stem cells to treat acute myocardial infarction: a systematic review
Martin-Rendon, E., Brunskill, S. J., Hyde, C. J., Stanworth, S. J., Mathur, A., & Watt, S. M. (2008) · European Heart Journal · doi:10.1093/eurheartj/ehn220 · Cited by 532
Lipinski, M. J., Biondi-Zoccai, G. G. L., Abbate, A., Khianey, R., Sheiban, I., Bartunek, J., Vanderheyden, M., Kim, H.-S., Kang, H.-J., Strauer, B. E., et al. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2007.07.041 · Cited by 509
Intramyocardial, Autologous CD34+ Cell Therapy for Refractory Angina
Losordo, D. W., Henry, T. D., Davidson, C., Sup Lee, J., Costa, M. A., Bass, T., Mendelsohn, F., Fortuin, F. D., Pepine, C. J., Traverse, J. H., et al. (2011) · Circulation Research · doi:10.1161/circresaha.111.245993 · Cited by 482
Self-citationTraverse, J. H. (2011) · JAMA · doi:10.1001/jama.2011.1670 · Cited by 405
Self-citationClinical Applications of Blood-Derived and Marrow-Derived Stem Cells for Nonmalignant Diseases
Burt, R. K. (2008) · JAMA · doi:10.1001/jama.299.8.925 · Cited by 354
van Ramshorst, J., Bax, J. J., Beeres, S. L. M. A., Dibbets-Schneider, P., Roes, S. D., Stokkel, M. P. M., de Roos, A., Fibbe, W. E., Zwaginga, J. J., Boersma, E., et al. (2009) · JAMA · doi:10.1001/jama.2009.685 · Cited by 300
Erbs, S., Linke, A., Adams, V., Lenk, K., Thiele, H., Diederich, K.-W., Emmrich, F., Kluge, R., Kendziorra, K., Sabri, O., et al. (2005) · Circulation Research · doi:10.1161/01.res.0000185811.71306.8b · Cited by 282
Kissel, C. K., Lehmann, R., Assmus, B., Aicher, A., Honold, J., Fischer-Rasokat, U., Heeschen, C., Spyridopoulos, I., Dimmeler, S., & Zeiher, A. M. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2007.01.095 · Cited by 241
Hendrikx, M., Hensen, K., Clijsters, C., Jongen, H., Koninckx, R., Bijnens, E., Ingels, M., Jacobs, A., Geukens, R., Dendale, P., et al. (2006) · Circulation · doi:10.1161/circulationaha.105.000505 · Cited by 235
Assmus, B., Fischer-Rasokat, U., Honold, J., Seeger, F. H., Fichtlscherer, S., Tonn, T., Seifried, E., Schächinger, V., Dimmeler, S., & Zeiher, A. M. (2007) · Circulation Research · doi:10.1161/01.res.0000264508.47717.6b · Cited by 217
Tse, H.-F., Thambar, S., Kwong, Y.-L., Rowlings, P., Bellamy, G., McCrohon, J., Thomas, P., Bastian, B., Chan, J. K. F., Lo, G., et al. (2007) · European Heart Journal · doi:10.1093/eurheartj/ehm485 · Cited by 194
Perin, E. C., Silva, G. V., Henry, T. D., Cabreira-Hansen, M. G., Moore, W. H., Coulter, S. A., Herlihy, J. P., Fernandes, M. R., Cheong, B. Y. C., Flamm, S. D., et al. (2011) · American Heart Journal · doi:10.1016/j.ahj.2011.01.028 · Cited by 181
Self-citationCD34-positive stem cells: in the treatment of heart and vascular disease in human beings.
Mackie, A. R., & Losordo, D. W. (2011) · Europe PMC (PubMed Central) · Cited by 133
Yao, K., Huang, R., Qian, J., Cui, J., Ge, L., Li, Y., Zhang, F., Shi, H., Huang, D., Zhang, S., et al. (2008) · Heart · doi:10.1136/hrt.2007.137919 · Cited by 80
Efficacy and Safety of Exercise Training in Patients With Chronic Heart Failure
O’Connor, C. M., Whellan, D. J., Lee, K. L., Keteyian, S. J., Cooper, L. S., Ellis, S. J., Leifer, E., Kraus, W. E., Kitzman, D. W., Blumenthal, J. A., et al. (2017) · Cited by 60
Self-citationCD133 positive progenitor endothelial cell lines from human cord blood
Paprocka, M., Krawczenko, A., Duś, D., Kantor, A., Carreau, A., Grillon, C., & Kiéda, C. (2011) · Cytometry Part A · doi:10.1002/cyto.a.21092 · Cited by 52
Willerson, J. T., Perin, E. C., Ellis, S. G., Pepine, C. J., Henry, T. D., Zhao, D. X.-M., Lai, D., Penn, M. S., Byrne, B. J., Silva, G., et al. (2010) · American Heart Journal · doi:10.1016/j.ahj.2010.03.029 · Cited by 44
Self-citationCiraci, E., Bella, S. D., Salvucci, O., Rofani, C., Segarra, M., Bason, C., Molinari, A., Maric, D., Tosato, G., & Berardi, A. C. (2011) · Blood · doi:10.1182/blood-2010-10-316596 · Cited by 27
Maret, E., Brudin, L. H., Lindström, L., Nylander, E., Ohlsson, J. L., & Engvall, J. E. (2008) · Cardiovascular Ultrasound · doi:10.1186/1476-7120-6-55 · Cited by 22
Cited by
Hare, J. M., Fishman, J. E., Gerstenblith, G., DiFede Velazquez, D. L., Zambrano, J. P., Suncion, V. Y., Tracy, M., Ghersin, E., Johnston, P. V., Brinker, J. A., et al. (2012) · JAMA · doi:10.1001/jama.2012.25321 · Cited by 1,192
Heart repair by reprogramming non-myocytes with cardiac transcription factors
Song, K., Nam, Y.-J., Luo, X., Qi, X., Tan, W., Huang, G. N., Acharya, A., Smith, C. L., Tallquist, M. D., Neilson, E. G., et al. (2012) · Nature · doi:10.1038/nature11139 · Cited by 1,147
Heldman, A. W., DiFede, D. L., Fishman, J. E., Zambrano, J. P., Trachtenberg, B. H., Karantalis, V., Mushtaq, M., Williams, A. R., Suncion, V. Y., McNiece, I. K., et al. (2014) · JAMA · doi:10.1001/jama.2013.282909 · Cited by 570
Cardiopoietic Stem Cell Therapy in Heart Failure
Bartunek, J., Behfar, A., Dolatabadi, D., Vanderheyden, M., Ostojic, M., Dens, J., El Nakadi, B., Banovic, M., Beleslin, B., Vrolix, M., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.02.071 · Cited by 493
Therapeutic approaches for cardiac regeneration and repair
Hashimoto, H., Olson, E. N., & Bassel-Duby, R. (2018) · Nature Reviews Cardiology · doi:10.1038/s41569-018-0036-6 · Cited by 415
Metadata
- Authors
- Perin, E. C., Willerson, J. T., Pepine, C. J., Henry, T. D., Ellis, S. G., Zhao, D. X. M., Silva, G. V., Lai, D., Thomas, J. D., Kronenberg, M. W., Martin, A. D., Anderson, R. D., Traverse, J. H., Penn, M. S., Anwaruddin, S., Hatzopoulos, A. K., Gee, A. P., Taylor, D. A., Cogle, C. R., Smith, D., Westbrook, L., Chen, J., Handberg, E., Olson, R. E., Geither, C., Bowman, S., Francescon, J., Baraniuk, S., Piller, L. B., Simpson, L. M., Loghin, C., Aguilar, D., Richman, S., Zierold, C., Bettencourt, J., Sayre, S. L., Vojvodic, R. W., Skarlatos, S. I., Gordon, D. J., Ebert, R. F., Kwak, M., Moyé, L. A., & Simari, R. D.
- Venue
- JAMA
- Publisher
- American Medical Association (AMA)
- Published
- 2012-04-25
- Volume
- 307
- Issue
- 16
- Pages
- 1717-26
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- OpenAlex
- W2143298795
- Cited by
- 460
- References
- 31
- FWCI
- 29.84
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.